BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frere C, Crichi B, Bournet B, Canivet C, Abdallah NA, Buscail L, Farge D. Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers (Basel). 2020;12. [PMID: 32722064 DOI: 10.3390/cancers12082028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Frere C. Burden of venous thromboembolism in patients with pancreatic cancer. World J Gastroenterol 2021; 27(19): 2325-2340 [PMID: 34040325 DOI: 10.3748/wjg.v27.i19.2325] [Reference Citation Analysis]
2 Hanna-Sawires RG, Groen JV, Hamming A, Tollenaar RAEM, Mesker WE, Luelmo SAC, Vahrmeijer AL, Bonsing BA, Versteeg HH, Klok FA, Mieog JSD. Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. Thromb Res 2021;207:134-9. [PMID: 34628229 DOI: 10.1016/j.thromres.2021.08.002] [Reference Citation Analysis]
3 Sandow LP, Cannon LA, Weston NR, Aung KL, Oo TH. The Clinical Applicability of Primary Thromboprophylaxis in Ambulatory Patients With Pancreatic Cancer. Pancreas 2021;50:494-9. [PMID: 33939659 DOI: 10.1097/MPA.0000000000001799] [Reference Citation Analysis]
4 Frere C, Connors JM, Farge D. Management of Cancer-Associated Thrombosis: An Evolving Area. Cancers (Basel) 2020;12:E2999. [PMID: 33081109 DOI: 10.3390/cancers12102999] [Reference Citation Analysis]
5 Jiménez-fonseca P, Gallardo E, Arranz Arija F, Blanco JM, Callejo A, Lavin DC, Costa Rivas M, Mosquera J, Rodrigo A, Sánchez Morillas R, Vares Gonzaléz M, Muñoz A, Carmona-bayonas A. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.02.020] [Reference Citation Analysis]
6 Htut TW, Thein KZ, Quick DP, Oo TH. Meta-analysis of randomized controlled trials on primary ambulatory thromboprophylaxis in patients with nonpancreatic gastrointestinal cancers receiving chemotherapy. Proc (Bayl Univ Med Cent) 2022;35:51-5. [PMID: 34970032 DOI: 10.1080/08998280.2021.1973340] [Reference Citation Analysis]